Notice: This company has been marked as potentially delisted and may not be actively trading. NASDAQ:LGST Semper Paratus Acquisition (LGST) Stock Price, News & Analysis Add Compare Share Share Stock Analysis Stock Analysis Get Semper Paratus Acquisition alerts: Email Address About Semper Paratus Acquisition Stock (NASDAQ:LGST) 30 days 90 days 365 days Advanced Chart Ad Paradigm PressThe True Potential for Civil War…Radical leftists mobilizing illegal immigrants, violence and looting, even marital law. 43% of respondents, for example, in a recent survey said they believe a civil war is “likely” in the next decade.Click here. Get LGST alerts:Sign Up Key Stats Today's Range$4.51▼$5.4050-Day Range$4.51▼$4.7852-Week Range$4.08▼$12.03Volume12,500 shsAverage Volume30,930 shsMarket Capitalization$71.35 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company OverviewSemper Paratus Acquisition Corporation does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. The company intends to acquire companies operating in the transportation, supply chain, and logistics industries. Semper Paratus Acquisition Corporation was incorporated in 2021 and is based in New York, New York. Semper Paratus Acquisition Corporation operates as a subsidiary of Ssvk Associates, Llc.Read More… The True Potential for Civil War… (Ad)Radical leftists mobilizing illegal immigrants, violence and looting, even marital law. 43% of respondents, for example, in a recent survey said they believe a civil war is “likely” in the next decade.Click here. Receive LGST Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Semper Paratus Acquisition and its competitors with MarketBeat's FREE daily newsletter. Email Address LGST Stock News HeadlinesTevogen Bio Holdings Inc., a Cell Therapy Company, Announces Completion of Business Combination and is to be Listed on Nasdaq Under Ticker TVGNFebruary 14, 2024 | finance.yahoo.comTevogen Bio Holdings Inc., a Cell Therapy Company, Announces Completion of Business Combination and is to be Listed on Nasdaq Under Ticker TVGNFebruary 14, 2024 | globenewswire.com10X More Profitable Than Physical Gold?The smart money is piling into gold and gold stocks. There's a backdoor gold play that could deliver 10 TIMES bigger gains than physical gold. That's why I've put together a special presentation on this opportunity...September 27, 2024 | Monument Traders Alliance (Ad)SPAC Semper Paratus shareholders okay merger with Tevogen BioFebruary 1, 2024 | msn.comSemper Paratus Acquisition Corporation’s Shareholders Approve Business Combination with Tevogen BioFebruary 1, 2024 | finance.yahoo.comSemper Paratus Acquisition Corporation Announces Anticipated Listing of Tevogen Bio Holdings Inc. on NasdaqJanuary 24, 2024 | finance.yahoo.comSemper Paratus Acquisition Corp (LGST)January 10, 2024 | investing.comTevogen Bio Inc. and Semper Paratus Acquisition Corporation Announce Effectiveness of Registration Statement for Business CombinationJanuary 5, 2024 | finance.yahoo.comSee More Headlines Company Calendar Today9/27/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Biological products, except diagnostic Sub-IndustryN/A Current SymbolNASDAQ:LGST CUSIPN/A CIK1860871 Webwww.semperparatusspac.com Phone646-807-8832FaxN/AEmployees2,021Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$4.41 million Net MarginsN/A Pretax MarginN/A Return on Equity-21.83% Return on Assets3.10% Debt Debt-to-Equity RatioN/A Current Ratio0.22 Quick Ratio0.22 Sales & Book Value Annual SalesN/A Price / SalesN/A Cash Flow$0.33 per share Price / Cash Flow13.74 Book Value($1.10) per share Price / Book-4.10Miscellaneous Outstanding Shares15,820,000Free Float6,864,000Market Cap$71.35 million OptionableNot Optionable Beta-0.08 7 Stocks to Buy And Hold ForeverClick the link below and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising. Get This Free Report This page (NASDAQ:LGST) was last updated on 9/27/2024 by MarketBeat.com Staff From Our Partners10X More Profitable Than Physical Gold?The smart money is piling into gold and gold stocks. There's a backdoor gold play that could deliver 10 TIM...Monument Traders Alliance | SponsoredPrepare for an election day stock surpriseDuring his 50 years on Wall Street, legendary stockpicker Marc Chaikin traded through 13 presidential election...Chaikin Analytics | SponsoredNvidia is Pivoting to Solve Big Tech’s $1 Trillion ProblemTaiwan Semiconductor, a partner of Nvidia’s for more than two decades, has seen its shares explode as much as ...Weiss Ratings | SponsoredThe death of Nvidia?Today, I’m warning of another looming catastrophe. Only this time, it’s not in pot stocks, cryptos, or U.S....Porter & Company | SponsoredBuffett Dumps $982 Million in BofA Stock—What Does He Know?Buffett's been eerily quiet about his reasons, but his actions speak volumes. When someone with his track reco...Genesis Gold Group | SponsoredThe $15 Stock Powering NVIDIA, TESLA and MicrosoftThe Biggest AI firms in the world...Tesla... Microsoft... NVIDIA... Are all relying on a little-known suppl...Behind the Markets | SponsoredKamala’s Dirty Election Move… RevealedAccording to former advisor to the CIA, the Pentagon and the White House Jim Rickards… Kamala and her puppe...Paradigm Press | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Semper Paratus Acquisition Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Semper Paratus Acquisition With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.